Treatment of Acne Scars With Erbium:Yttrium Aluminum Garnet (Er:YAG) Laser Examined Under OCT

Withdrawn before enrolling · Not applicable

Conditions studied: Acne Vulgaris

In brief

This study is examining the effects of the 2940 nm Er:YAG on atrophic facial acne scars under optical coherence tomography in terms of blood flow, vessel shape, skin roughness, collagen content, and epidermal thickness.

Key facts

Study ID

NCT03333759

Run by

University of Miami

People needed

0

Starts

2018-08-01

Expected to finish

2018-12-01

Last updated by the study team

2018-07-26

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients should be 18-90 years of age
• Patients should have Fitzpatrick skin types of I-III
• Patients should have at least mild acne

You may not qualify if…

• The patient should not be receiving any additional systemic, topical, or intralesional treatment of the scars during the study
• Pregnant or lactating females
• Fitzpatrick skin type of IV-VI
• A history of keloids or hypertrophic scars
• Scleroderma
• Photosensitivity
• Botulinum toxin injection, facial laser resurfacing, chemical peels, fillers, or usage of oral retinoid within the last 6 months
• Subjects with a known history of herpes simplex

Where it is running

• Sylvester Comprehensive Cancer Center — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.